Early Value Assessment in Gene Therapy Clinical Trial Design Case Study Early Value Assessment in Gene Therapy Clinical Trial Design A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…CertaraFebruary 12, 2021
Why Consistency in Patient Safety Narratives is Crucial Blog Why Consistency in Patient Safety Narratives is Crucial “You would not be able to tell 40 different writers were authoring these. It looked…CertaraFebruary 9, 2021
BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection Publication BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection Abstract During a pandemic caused by a novel pathogen (NP), drug repurposing offers the potential…CertaraFebruary 9, 2021
RAPS Sponsored Webinar: Efficiency and Technology Pave the Way for the New Age of Narrative Writing On-Demand Webinar RAPS Sponsored Webinar: Efficiency and Technology Pave the Way for the New Age of Narrative Writing Narratives are an integral part of medical writing. Sponsors sometimes need to prepare large…CertaraFebruary 8, 2021
Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines White Paper Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines CertaraFebruary 3, 2021
8 Tips for Successfully Developing Oligonucleotide Therapies Blog 8 Tips for Successfully Developing Oligonucleotide Therapies By Eva Gil Berglund and Nathalie H Gosselin Oligonucleotide therapeutics are a validated class of…CertaraFebruary 1, 2021
BaseCase Interactive for Medical Affairs Brochure BaseCase Interactive for Medical Affairs CertaraJanuary 28, 2021
Simcyp® PBPK Simulator Brochure Simcyp® PBPK Simulator Streamlines drug development by using PBPK modeling to predict drug behavior in virtual populations, optimize…CertaraJanuary 22, 2021
How drug developers can avoid these common mistakes to secure a deal On-Demand Webinar How drug developers can avoid these common mistakes to secure a deal Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…CertaraJanuary 21, 2021
Making your biotech program investor-ready On-Demand Webinar Making your biotech program investor-ready Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…CertaraJanuary 21, 2021